Olean Times Herald

CAMBRIDGE, Mass. , ROTTERDAM, Netherlands and SHANGHAI , April 9, 2025 /PRNewswire/ --HarbourBioMed (HKEX: 02142), a global biopharmaceutical company ...

CAMBRIDGE, Mass. , ROTTERDAM, Netherlands and SHANGHAI , March 31, 2025 /PRNewswire/ -- HarbourBioMed ("HBM" or the "Company"; HKEX: 02142), a global ...

SHANGHAI , CAMBRIDGE, Mass. and ROTTERDAM, Netherlands , March 21, 2025 /PRNewswire/ -- HarbourBioMed (HKEX: 02142), a global biopharmaceutical compan...

- Élancé Therapeutics aims to improve current obesity treatment, specifically to increase overall body weight loss and fat mass loss, but preserve and...

CAMBRIDGE, Mass. , ROTTERDAM, Netherlands and SHANGHAI , March 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical compa...

CAMBRIDGE, Mass. , ROTTERDAM, Netherlands and SHANGHAI , March 10, 2025 /PRNewswire/ --HarbourBioMed (HKEX: 02142), a global biopharmaceutical company...

CAMBRIDGE, Mass. , ROTTERDAM, Netherlands and SHANGHAI , Feb. 25, 2025 /PRNewswire/ -- HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnolo...

CAMBRIDGE, Mass. , ROTTERDAM, Netherlands and SHANGHAI , Feb. 20, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharma...

CAMBRIDGE, Mass. , ROTTERDAM, Netherlands and SHANGHAI , Feb. 13, 2025 /PRNewswire/ -- HarbourBioMed (the "Company"; HKEX: 02142), a global biopharmac...